Performance evaluation test of rapid diagnostic kit for testing SARS-CoV-2/Influenza virus infection

Evaluation of rapid diagnostic method for SARS-CoV-2/Influenza virus infection - Evaluation of rapid diagnostic method for SARS-CoV-2/Influenza virus infection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000048803

Enrollment

200

Registered

2022-09-01

Start date

2022-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 infection Influenza virus infection

Interventions

Sample collection, assay with test kit

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients that visit the medical institution during this study, and include the following conditions: 1) Patients with symptoms suspected of COVID-19 infection or Influenza virus infection. 2) Patients who gave consent to this study.

Exclusion criteria

Exclusion criteria: 1) Patients for whom sample collection is considered difficult. 2) Patients who gave consent to this study.

Design outcomes

Primary

Measure	Time frame
Sensitivity, specificity and limits of detection for rapid diagnostic methods for SARS-CoV-2 and Influenza virus infection	—

Countries

Japan

Contacts

Public ContactYuta Maehara

Sekisui Medical Co., Ltd. Research & Development

yuta.maehara@sekisui.com03-3272-0677

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026